188 related articles for article (PubMed ID: 22407324)
1. Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.
Zamirska A; Matusiak Ł; Dziegiel P; Szybejko-Machaj G; Szepietowski JC
Pathol Oncol Res; 2012 Oct; 18(4):849-55. PubMed ID: 22407324
[TBL] [Abstract][Full Text] [Related]
2. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
Talghini S; Halimi M; Baybordi H
Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein 3 expression in normal skin and malignant skin lesions.
Pula B; Tazbierski T; Zamirska A; Werynska B; Bieniek A; Szepietowski J; Rys J; Dziegiel P; Podhorska-Okolow M
Pathol Oncol Res; 2015 Jan; 21(1):187-93. PubMed ID: 25015776
[TBL] [Abstract][Full Text] [Related]
5. Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis.
Wojciechowska-Zdrojowy M; Szepietowski JC; Matusiak Ł; Dzięgiel P; Puła B
Anticancer Res; 2016 Apr; 36(4):1591-7. PubMed ID: 27069135
[TBL] [Abstract][Full Text] [Related]
6. Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin.
Bosic MM; Brasanac DC; Stojkovic-Filipovic JM; Zaletel IV; Gardner JM; Cirovic SL
Exp Mol Pathol; 2016 Jun; 100(3):378-85. PubMed ID: 27019369
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
8. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
9. Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Ayva SK; Karabulut AA; Akatli AN; Atasoy P; Bozdogan O
Pathol Res Pract; 2013 Oct; 209(10):627-34. PubMed ID: 23948694
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
11. Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.
Brasanac D; Stojkovic-Filipovic J; Bosic M; Tomanovic N; Manojlovic-Gacic E
J Cutan Pathol; 2016 Mar; 43(3):200-10. PubMed ID: 26349899
[TBL] [Abstract][Full Text] [Related]
12. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
14. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein immunolocalization in actinic skin nonmelanoma carcinomas.
Borges Júnior PC; Ribeiro RI; Cardoso SV; Berbet AL; Rocha A; Espindola FS; Loyola AM
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):165-9. PubMed ID: 17525628
[TBL] [Abstract][Full Text] [Related]
16. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
[TBL] [Abstract][Full Text] [Related]
17. The expression pattern and functional role of REIC/Dkk-3 in the development of cutaneous squamous cell carcinoma.
Shin JM; Choi DK; Kang HY; Sohn KC; Lee Y; Kim CD; Lee JH; Park BC
J Dermatol Sci; 2016 Oct; 84(1):88-96. PubMed ID: 27354306
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma.
Chen S; Takahara M; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2008 Sep; 159(4):952-5. PubMed ID: 18647309
[TBL] [Abstract][Full Text] [Related]
19. The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions.
Scola N; Gambichler T; Saklaoui H; Bechara FG; Georgas D; Stücker M; Gläser R; Kreuter A
Br J Dermatol; 2012 Sep; 167(3):591-7. PubMed ID: 22709331
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]